Mike Biddle is listed as a director on 2 SEC Form D filings by 1 issuer between Aug 2019 and Dec 2019: Syzygy Plasmonics Inc. (Houston, TX — industry reported as "Other" — 2019; $76.7M reported sold to 31 investors).
What this means One deal on file with the SEC, filed Dec 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ann DeWitt (2 shared filings), Don Kendall (2 shared filings), Suman Khatiwada (2 shared filings) and Trevor Best (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mike. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Mike Biddle and found 4 differences: Form D filed 17 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.